echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Innovative methods redefine data analysis in proteomics research

    Innovative methods redefine data analysis in proteomics research

    • Last Update: 2021-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 1, 2021, Philadelphia/PRNewswire/—ASMS collaborated to provide proteomics researchers with advanced mass spectrometry software, which greatly improves peptide identification and quantification capabilities through the use of artificial intelligence (AI) and deep learning, from the data obtained And then derive more and more in-depth biological information
    .

    Thermo Scientific Proteome Discoverer 3.
    0 software combines MSAID's CHIMERYS, using artificial intelligence (AI) to greatly increase the recognition rate and number of unique peptides in proteomics data
    .


    Compared with existing methods, CHIMERYS has identified the smallest set of peptides that can explain the obtained tandem mass spectrum.


    At the 69th American Society for Mass Spectrometry (ASMS) Mass Spectrometry and Related Topics Conference held from October 31 to November 4 at the Philadelphia Convention Center, Pennsylvania, Thermo Fisher Scientific and MSAID demonstrated their new software solutions Scheme
    .

    "Previous technology cannot fully explain the data generated using mass spectrometry, because the mass spectrum may contain multiple co-separated peptide fragments, and these fragments cannot be identified using current algorithms," Thermo Fisher is responsible for R&D, chromatography and mass spectrometry.
    Said August Specht, vice president of
    .


    "By using Proteome Discoverer 3.


    MSAID CEO Martin Frejno said: "Chimeric spectroscopy is a long-term problem of mass spectrometry-based proteomics
    .


    With CHIMERYS, we reimagined tandem mass spectrometry and used artificial intelligence to solve it


    The Proteome Discoverer 3.
    0 software version also includes an updated INFERYS prediction model, expands the support for tandem mass markers (TMT), collision-induced dissociation (CID), and provides improved results for immunopeptidomics
    .


    By combining Proteome Discoverer 3.


    For more information about Thermo Scientific Proteome Discoverer 3.
    0 software and MSAID's CHIMERYS, please visitor join us in ASMS 2021 from October 31 to November 4, 2021
    .

    Thermo Fisher Scientific Co.
    , Ltd.
    is the world's leading scientific service company with annual revenue of approximately US$35 billion
    .


    Our mission is to let our customers make the world healthier, cleaner and safer


    Media contact information:

    Laura Bright
    Thermo Fisher Scientific
    +1 562-335-8318
    laura.


    bright@thermofisher.
    com

    Janice Foley
    +1 617-823-5555
    jfoley@biostratamarketing.


    com

    SOURCE Thermo Fisher Scientific

             

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.